StonvexLoading…
StonvexStonvexStonvexCore line items from PFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.53B | $15.63B | $11.05B | $7.37B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $424.60M | $1.19B | $668.10M | $454.30M |
EPS (Diluted) | $1.93 | $5.25 | $2.95 | $2.00 |
Total Assets | $332.70B | $341.38B | $334.49B | $323.10B |
Total Liabilities | $320.31B | $328.99B | $322.36B | $311.25B |
Cash & Equivalents | $4.05B | $4.43B | $5.14B | $3.66B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 216.45M | 217.38M | 220.52M | 223.19M |